论文部分内容阅读
随着人口老龄化的加剧,诊治过程中合并患有严重外科疾患需手术治疗又合并严重冠状动脉疾病需经皮冠状动脉介入(PCI)治疗的患者逐年增多,给抗凝、抗血小板聚集治疗带来了巨大矛盾和风险,在接受抗血小板聚集药物治疗并且接受非心脏外科手术的患者,目前尚少见持续应用抗血小板聚集药物与临时中断抗血小板聚集治疗的临床获益和风险性比较的随机对照试验或前瞻性研究。现将我院自2006年1月—2011年12月共6例相关患者的诊治体会报告如下。
With the aging of the population, the number of patients requiring surgical treatment combined with severe coronary artery disease requiring percutaneous coronary intervention (PCI) during the course of diagnosis and treatment is increasing year by year, and anticoagulant and anti-platelet aggregation therapy tapes There have been few randomized controlled trials of sustained antiplatelet aggregation and clinical benefit and risk of temporary interruption of antiplatelet aggregation in patients receiving antiplatelet drug therapy and undergoing noncardiac surgery Experimental or prospective study. Now in our hospital from January 2006 -2011 in December a total of 6 cases of related patient diagnosis and treatment report is as follows.